StreetInsider.com News Articles

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l.

Fri, 14 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260814/26932148.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Nextech Crossover I GP S.a r.l.

Fri, 14 Aug 2026 16:49:00 -0400

si-local-file:///var/storage/secattach/20260814/26932148.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC

Fri, 14 Aug 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260814/26930817.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: TCG Crossover GP II, LLC

Fri, 14 Aug 2026 16:20:00 -0400

si-local-file:///var/storage/secattach/20260814/26930817.html

Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: GOLDMAN SACHS GROUP INC

Fri, 14 Aug 2026 14:12:00 -0400

si-local-file:///var/storage/secattach/20260814/26928837.html

Form SCHEDULE 13G Tango Therapeutics, Inc. Filed by: GOLDMAN SACHS GROUP INC

Fri, 14 Aug 2026 14:12:00 -0400

si-local-file:///var/storage/secattach/20260814/26928837.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Woodline Partners LP

Fri, 14 Aug 2026 11:05:00 -0400

si-local-file:///var/storage/secattach/20260814/26927053.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Woodline Partners LP

Fri, 14 Aug 2026 11:05:00 -0400

si-local-file:///var/storage/secattach/20260814/26927053.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.

Fri, 14 Aug 2026 08:24:00 -0400

si-local-file:///var/storage/secattach/20260814/26925038.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.

Fri, 14 Aug 2026 08:24:00 -0400

si-local-file:///var/storage/secattach/20260814/26925038.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.

Wed, 12 Aug 2026 12:02:00 -0400

si-local-file:///var/storage/secattach/20260812/26911208.html

Form SCHEDULE 13G/A Tango Therapeutics, Inc. Filed by: Adage Capital Management, L.P.

Wed, 12 Aug 2026 12:02:00 -0400

si-local-file:///var/storage/secattach/20260812/26911208.html

Tango Therapeutics Inc. (TNGX) PT Raised to $35 at Guggenheim

Wed, 12 Aug 2026 06:57:05 -0400

(Updated - August 12, 2026 6:57 AM EDT)

Guggenheim analyst Charles Zhu raised the price target on Tango Therapeutics Inc. (NASDAQ: TNGX) to $35.00 (from $32.00) while maintaining a Buy rating.

The analyst commented: "TNGX reported 2Q26 results and highlighted that they will finalize the design of a planned Phase 3 randomized controlled trial for vopimetostat (PRMT5i) + RAS inhibitors (RVMD) in 1L PDAC in 2H26. Our discussion with mgmt focused on upcoming data disclosure at ESMO 2026 and potential registrational design in 1L PDAC, as well as recent changes in leadership. Mgmt remains confident in upcoming discussions with the FDA and

Tango Therapeutics Inc. (TNGX) PT Raised to $35 at Guggenheim

Wed, 12 Aug 2026 06:57:05 -0400

(Updated - August 12, 2026 6:57 AM EDT)

Guggenheim analyst Charles Zhu raised the price target on Tango Therapeutics Inc. (NASDAQ: TNGX) to $35.00 (from $32.00) while maintaining a Buy rating.

Form 8-K Tango Therapeutics, Inc. For: Aug 11

Tue, 11 Aug 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260811/26907016.html

Form 8-K Tango Therapeutics, Inc. For: Aug 11

Tue, 11 Aug 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260811/26907016.html

Form 424B5 Tango Therapeutics, Inc.

Tue, 11 Aug 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260811/26906985.html

Form 424B5 Tango Therapeutics, Inc.

Tue, 11 Aug 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260811/26906985.html

NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float